On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Marianne Clancy, Executive Director at Cure HHT, about the foundation and their goal of reducing the number of undiagnosed cases of HHT.
"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...
"We don't endeavor to make elite athletes better. We endeavor to make society healthier." - Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics Welcome...
"I think all disciplines go through a process, a journey of being imagined and then becoming a science and then becoming a discipline of...